Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2003;34:2132-2137
Published online before print August 7, 2003, doi: 10.1161/01.STR.0000086466.32421.F4
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/9/2132    most recent
01.STR.0000086466.32421.F4v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cherian, P.
Right arrow Articles by Yi, Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cherian, P.
Right arrow Articles by Yi, Q.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Platelets
Right arrow Endothelium/vascular type/nitric oxide

(Stroke. 2003;34:2132.)
© 2003 American Heart Association, Inc.


Original Contributions

Endothelial and Platelet Activation in Acute Ischemic Stroke and Its Etiological Subtypes

Paul Cherian, MBBS; Graeme J. Hankey, MD; John W. Eikelboom, MBBS; Jim Thom, M(App)Sc; Ross I. Baker, MBBS; Andrew McQuillan, MBBS; Janelle Staton, PhD Qilong Yi, PhD

From the Department of Medicine, University of Western Australia, Perth, Australia (P.C., G.J.H., J.W.E., R.I.B.); Stroke Unit, Department of Neurology (P.C., G.J.H.) and Department of Haematology (J.W.E., J.T., R.I.B., A.M., J.S.), Royal Perth Hospital, Perth, Australia; and Biostatistics Department, Princess Margaret Hospital, Toronto, Canada (Q.Y.).

Correspondence to Clinical Professor Graeme J. Hankey, Consultant Neurologist and Head of Stroke Unit, Royal Perth Hospital, Box X2213 GPO, Perth WA 6897, Australia. E-mail gjhankey{at}cyllene.uwa.edu.au

Background and Purpose— Activation of endothelial cells and platelets is an important mediator of atherothrombosis. Markers of endothelial cell and platelet activation such as soluble adhesion molecules can be measured in plasma. We hypothesized that patients with acute ischemic stroke would have increased blood concentrations of soluble E-selectin and von Willebrand factor (vWF), primarily reflecting activation of endothelial cells, and increased concentrations of soluble P-selectin and platelet-derived microvesicles (PDM), primarily reflecting activation of platelets, compared with healthy controls. We also hypothesized that these markers would be differentially elevated in ischemic stroke caused by large- and small-artery atherothrombosis compared with cardiogenic embolism.

Methods— We conducted a case-control study of 200 hospital-referred cases of first-ever ischemic stroke and 205 randomly selected community controls stratified by age, sex, and postal code. Using established criteria, we classified cases of stroke by etiological subtype in a blinded fashion. The prevalence of vascular risk factors and blood concentrations of E-selectin, P-selectin, vWF antigen, and PDM were determined in stroke cases within 7 days and at 3 to 6 months after stroke and in controls.

Results— Mean blood concentrations of soluble E-selectin, P-selectin, and PDM within 7 days of stroke onset were all significantly higher in cases compared with controls. At 3 to 6 months after stroke, the mean blood concentrations of E-selectin and P-selectin fell significantly below that of controls, and PDM concentrations remained elevated. There was a strong, graded, and independent (of age, sex, and vascular risk factors) association between increasing blood concentrations of E-selectin during the acute phase and all etiological subtypes of ischemic stroke, particularly ischemic stroke caused by large-artery atherothrombosis. There was also a significant, graded, and independent association between increasing blood concentrations of vWF during the acute phase and ischemic stroke caused by large-artery atherothrombosis.

Conclusions— We have demonstrated significant associations between acute elevation of blood markers of endothelial cell and platelet activation and ischemic stroke and between acute elevation of blood markers of endothelial cell activation and ischemic stroke caused by large-artery atherothrombosis. Persistent elevated blood concentrations of PDM may be a marker of increased risk of ischemic stroke.


Key Words: activation • endothelium • platelets • selectins • stroke, acute • stroke, ischemic




This article has been cited by other articles:


Home page
CLIN APPL THROMB HEMOSTHome page
M. Cleanthis, J. Smout, V. Bhattacharya, H. Ashour, A. Dyker, G. Ashley Ford, D. P Mikhailidis, and G. P. Stansby
Soluble but Not Platelet P-selectin Correlates With Spontaneous Platelet Aggregation: A Pilot Study
Clinical and Applied Thrombosis/Hemostasis, April 1, 2008; 14(2): 227 - 233.
[Abstract] [PDF]


Home page
haematolHome page
L. Navarro-Nunez, M. L. Lozano, J. Rivera, J. Corral, V. Roldan, R. Gonzalez-Conejero, J. A. Iniesta, J. Montaner, V. Vicente, and C. Martinez
The association of the {beta}1-tubulin Q43P polymorphism with intracerebral hemorrhage in men
Haematologica, April 1, 2007; 92(4): 513 - 518.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. L. Chen, P. Y. Wang, W. H. Sheu, Y. T. Chen, Y. P. Ho, H. H. Hu, and H. Y. Hsu
Changes of brachial flow-mediated vasodilation in different ischemic stroke subtypes.
Neurology, September 26, 2006; 67(6): 1056 - 1058.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C J M Frijns, K M Kasius, A Algra, R Fijnheer, and G J E Rinkel
Endothelial cell activation markers and delayed cerebral ischaemia in patients with subarachnoid haemorrhage
J. Neurol. Neurosurg. Psychiatry, July 1, 2006; 77(7): 863 - 867.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K. K. Ray, D. A. Morrow, C. M. Gibson, S. Murphy, E. M. Antman, E. Braunwald, and for the ENTIRE-TIMI 23 Study Group
Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy
Eur. Heart J., March 1, 2005; 26(5): 440 - 446.
[Abstract] [Full Text] [PDF]